Attorney General Paxton accuses Pfizer of violating the Texas Deceptive Trade Practices Act through “false, deceptive, and misleading acts and practices.”
The lawsuit highlights the company’s claims that the vaccine has a 95% efficacy rate against COVID-19 infection, stating that this was based on “relative risk reduction” in Pfizer’s initial short-term clinical trial results.
It is argued that this figure is a misleading statistic that should not be used to unduly influence consumer choice, especially since the Food and Drug Administration (FDA) has indicated that long-term vaccine protection could not accurately be predicted at that point. Read more:
